[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Turkey Diabetes Market Report: 2019 - 2024

June 2019 | 90 pages | ID: TA8A194D1EDEN
IMARC Group

US$ 1,999.00

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
IMARC’s new report “Turkey Diabetes Market Report: 2019 - 2024” provides an analytical and statistical insight into the Turkey diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Turkey. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Turkey diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Turkey diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the Turkey diabetes epidemiology and its dynamics:

Focus of the Analysis:

Historical, current and future prevalence of diabetes in Turkey
Historical, current and future prevalence of type-1 and type-2 diabetes in Turkey
Historical, current and future prevalence of diabetes in the urban and rural regions in Turkey
Historical, current and future prevalence of diabetes among males and females in Turkey
Historical, current and future prevalence of diabetes among various age groups in Turkey
Historical, current and future diagnosis rates for diabetes in Turkey
Historical, current and future drug treatment rates for diabetes in Turkey

Comprehensive situation analysis of the Turkey Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

Performance of the Oral Antidiabetics market in Turkey
Performance of key classes
Performance of key players
Market outlook

Comprehensive situation analysis of the Turkey Insulin market and its dynamics:

Focus of the Analysis:

Performance of the Insulin market in Turkey
Performance of key classes
Performance of key players
Market outlook
1 PREFACE

2 SCOPE AND METHODOLOGY

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
  2.3.1 Primary Sources
  2.3.2 Secondary Sources
2.4 Market Estimation
  2.4.1 Bottom-Up Approach
  2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 EXECUTIVE SUMMARY

4 INTRODUCTION

4.1 Overview
4.2 Key Industry Trends

5 DIABETES DISEASE OVERVIEW

5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
  5.2.1 Diagnosis
  5.2.2 Treatment
5.3 Diabetes Complications

6 TURKEY DIABETES EPIDEMIOLOGY

6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group

7 TURKEY DIABETES MARKET

7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
  7.4.1 Overview
  7.4.2 Strengths
  7.4.3 Weaknesses
  7.4.4 Opportunities
  7.4.5 Threats
7.5 Value Chain Analysis
7.6 Porter’s Five Forces Analysis
  7.6.1 Overview
  7.6.2 Bargaining Power of Buyers
  7.6.3 Bargaining Power of Suppliers
  7.6.4 Degree of Competition
  7.6.5 Threat of New Entrants
  7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
  7.7.1 Turkey Oral Antidiabetics Market
    7.7.1.1 Historical Market Trends
    7.7.1.2 Market Breakup by Class
    7.7.1.3 Market Shares of Key Players
    7.7.1.4 Market Forecast
  7.7.2 Turkey Insulin Market
    7.7.2.1 Historical Market Trends
    7.7.2.2 Market Breakup by Class
    7.7.2.3 Market Shares of Key Players
    7.7.2.4 Market Forecast

8 COMPETITIVE LANDSCAPE

8.1 Competitive Structure
8.2 Profiles of Key Players

LIST OF TABLES

Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2018 & 2024
Table 3: Turkey: Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 4: Turkey (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 5: Turkey (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 6: Turkey (Male & Female): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 7: Turkey: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79 - in 000), 2011, 2018 & 2024
Table 8: Turkey: Diabetes Drug Market: Competitive Structure

LIST OF FIGURES

Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2018 & 2024
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: Turkey: Total Number of Diabetes Patients (in 000), 2011-2018
Figure 6: Turkey: Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 7: Turkey (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 8: Turkey (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 9: Turkey (Urban & Rural): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 10: Turkey (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 11: Turkey (Male & Female): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 12: Turkey (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 13: Turkey: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, in 000), 2011-2018
Figure 14: Turkey: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, in 000), 2019-2024
Figure 15: Turkey: Diabetes Drug Industry Overview
Figure 16: Turkey: Diabetes Drug Market: Sales Value (in Million US$), 2011-2018
Figure 17: Turkey: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 18: Turkey: Diabetes Drug Market: SWOT Analysis
Figure 19: Turkey: Diabetes Drug Market: Value Chain Analysis
Figure 20: Turkey: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: Turkey: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2018
Figure 22: Turkey: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2019-2024
Figure 23: Turkey: Oral Antidiabetics Market: Sales Value (in Million US$), 2011-2018
Figure 24: Turkey: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2011 & 2018
Figure 25: Turkey: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: Turkey: Oral Antidiabetics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 27: Turkey: Insulin Market: Sales Value (in Million US$), 2011-2018
Figure 28: Turkey: Breakup of Insulin Market by Class (in %), 2011 & 2018
Figure 29: Turkey: Insulin Market: Sales Share of Key Players (in %)
Figure 30: Turkey: Insulin Market Forecast: Sales Value (in Million US$), 2019-2024


More Publications